SW
LLY icon

SlateStone Wealth’s Eli Lilly LLY Stock Holding History

SlateStone Wealth’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.53M Buy
5,446
+1,068
+24% +$1.09M 0.5% 60
2026
Q1 		$4.03M Sell
4,378
-25
-0.6% -$25.3K 0.33% 72
2025
Q4 		$4.73M Buy
4,403
+6
+0.1% +$5.74K 0.4% 69
2025
Q3 		$3.35M Buy
4,397
+1,597
+57% +$1.19M 0.29% 85
2025
Q2 		$2.18M Sell
2,800
-200
-7% -$155K 0.2% 97
2025
Q1 		$2.48M Sell
3,000
-275
-8% -$229K 0.25% 89
2024
Q4 		$2.53M Buy
3,275
+131
+4% +$108K 0.25% 90
2024
Q3 		$2.79M Buy
3,144
+81
+3% +$72.8K 0.25% 89
2024
Q2 		$2.77M Sell
3,063
-103
-3% -$82.4K 0.3% 78
2024
Q1 		$2.46M Buy
3,166
+33
+1% +$23.5K 0.25% 85
2023
Q4 		$1.83M Sell
3,133
-35
-1% -$20.4K 0.24% 90
2023
Q3 		$1.7M Buy
3,168
+450
+17% +$232K 0.25% 88
2023
Q2 		$1.27M Buy
2,718
+117
+4% +$49.1K 0.24% 81
2023
Q1 		$893K Sell
2,601
-103
-4% -$34.7K 0.18% 99
2022
Q4 		$989K Buy
2,704
+77
+3% +$27.3K 0.24% 83
2022
Q3 		$849K Buy
2,627
+211
+9% +$66.9K 0.23% 91
2022
Q2 		$783K Sell
2,416
-63
-3% -$18.9K 0.2% 87
2022
Q1 		$710K Sell
2,479
-1,385
-36% -$356K 0.16% 94
2021
Q4 		$1.07M Buy
3,864
+1,105
+40% +$280K 0.23% 81
2021
Q3 		$637K Buy
2,759
+937
+51% +$231K 0.15% 106
2021
Q2 		$418K Sell
1,822
-51
-3% -$10.2K 0.1% 129
2021
Q1 		$350K Buy
1,873
+47
+3% +$9.19K 0.09% 129
2020
Q4 		$308K Sell
1,826
-7,513
-80% -$1.12M 0.08% 139
2020
Q3 		$1.38M Buy
9,339
+2,484
+36% +$384K 0.3% 83
2020
Q2 		$1.13M Buy
6,855
+625
+10% +$95.9K 0.25% 91
2020
Q1 		$864K Buy
6,230
+2,006
+47% +$276K 0.25% 90
2019
Q4 		$555K Buy
+4,224
New +$490K 0.13% 123

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

SlateStone Wealth's LLY Position: Q2 2026 in Review

SlateStone Wealth increased its Eli Lilly (LLY) stake by 24% in Q2 2026, buying an estimated $1.09M and bringing the position to 5,446 shares worth $6.53M. The position accounts for 0.5% of the portfolio, ranked #60.

SlateStone Wealth first reported a position in LLY in Q4 2019 and has held it in 27 quarters since. 2,015 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • SlateStone Wealth held 5,446 shares of Eli Lilly worth $6.53M as of Q2 2026.
  • SlateStone Wealth bought 1,068 Eli Lilly shares in Q2 2026, an estimated $1.09M.
  • Eli Lilly made up 0.5% of SlateStone Wealth's portfolio in Q2 2026, its #60 holding.
  • SlateStone Wealth first reported a position in Eli Lilly in Q4 2019 and has held it in 27 quarters since.
  • 2,015 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on SlateStone Wealth's 13F filing for Q2 2026, filed 20 Jul 2026.